93
Views
0
CrossRef citations to date
0
Altmetric
General Medicine

Further Refinement is Required for Patient-Reported Outcome Scales for Respiratory Diseases Based on Traditional Chinese Medicine Theory for Applicability

ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 6099-6113 | Received 02 Sep 2023, Accepted 14 Dec 2023, Published online: 22 Dec 2023

References

  • FDA. CDER patient-focused drug development; 2022. Available from: https://www.fda.gov/drugs/development-approval-process-drugs/cder-patient-focused-drug-development. Accessed June 2, 2023.
  • Hareendran A, Gnanasakthy A, Winnette R, Revicki D. Capturing patients’ perspectives of treatment in clinical trials/drug development. Contemp Clin Trials. 2012;33(1):23–28. doi:10.1016/j.cct.2011.09.015
  • McColl E, Junghard O, Wiklund I, Revicki DA. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians’ assessments agree with those of their patients? Am J Gastroenterol. 2005;100(1):11–18. doi:10.1111/j.1572-0241.2005.40945.x
  • U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4(1):79. doi:10.1186/1477-7525-4-79
  • Calvert M, Kyte D, Price G, Valderas JM, Hjollund NH. Maximising the impact of patient reported outcome assessment for patients and society. BMJ. 2019;364:k5267. doi:10.1136/bmj.k5267
  • Guo J, Chen Y, Zhang W, Tong S, Dong J. Moderate and severe exacerbations have a significant impact on health-related quality of life, utility, and lung function in patients with chronic obstructive pulmonary disease: a meta-analysis. Int J Surg. 2020;78:28–35. doi:10.1016/j.ijsu.2020.04.010
  • Magge A, Ashraf S, Quittner AL, Metersky ML. Quality of life in patients with bronchiectasis: a 2-year longitudinal study. Ann Transl Med. 2019;7(14):334. doi:10.21037/atm.2019.06.62
  • Cox IA, Borchers Arriagada N, de Graaff B, et al. Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Eur Respir Rev. 2020;29(158):200154. doi:10.1183/16000617.0154-2020
  • Molen TVD, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes. 2003;1(1):13. doi:10.1186/1477-7525-1-13
  • Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321
  • Stewart AL, Napoles-Springer A. Health-related quality-of-life assessments in diverse population groups in the United States. Med Care. 2000;38(9 Suppl):II102–II124. doi:10.1097/00005650-200009002-00017
  • Zhang S, Chen Y. Research status of patient reported outcome scale of traditional Chinese medicine. Zhong Hua Zhong Yi Yao Za Zhi. 2018;33(03):1026–1029.
  • Haifeng W, Hailong Z, Jiansheng L, et al. Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Complement Ther Med. 2015;23(4):603–611. doi:10.1016/j.ctim.2015.06.015
  • Chen X, Kang F, Lai J, Deng X, Guo X, Liu S. Comparative effectiveness of phlegm-heat clearing Chinese medicine injections for AECOPD: a systematic review and network meta-analysis. J Ethnopharmacol. 2022;292:115043. doi:10.1016/j.jep.2022.115043
  • Huang SY, Cui HS, Lyu MS, Huang GR, Hou D, Yu MX. Efficacy of traditional Chinese medicine injections for treating idiopathic pulmonary fibrosis: a systematic review and network meta-analysis. PLoS One. 2022;17(7):e0272047. doi:10.1371/journal.pone.0272047
  • Wang Q, Wang Q, Wang SF, et al. Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis. Curr Oncol. 2017;24(4):e269–e276. doi:10.3747/co.24.3561
  • Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171–1179. doi:10.1007/s11136-017-1765-4
  • Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–745. doi:10.1016/j.jclinepi.2010.02.006
  • Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol. 2010;10(1):22. doi:10.1186/1471-2288-10-22
  • Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a delphi study. Qual Life Res. 2018;27(5):1159–1170. doi:10.1007/s11136-018-1829-0
  • Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–1157. doi:10.1007/s11136-018-1798-3
  • Prinsen CA, Vohra S, Rose MR, et al. How to select outcome measurement instruments for outcomes included in a “core outcome set” - a practical guideline. Trials. 2016;17(1):449. doi:10.1186/s13063-016-1555-2
  • Ren M, Sun ZT, Feng JH, et al. Evaluating of self-reported scale for patients with chronic obstruction pulmonary disease in TCM. Tianjin J Tradit Chin Med. 2011;28(02):101–103.
  • Zhou D. Application and Evaluation of the “Patient Reported Outcome” Traditional Chinese Medicine Evaluation Scale for Chronic Obstructive Pulmonary Disease. Hunan: Hunan University of Chinese Medicine; 2016.
  • Li JS, Wang MH, Yu XQ, Li SY, Xie Y. Development and validation of a patient reported outcome instrument for chronic obstructive pulmonary diseases. Chin J Integr Med. 2015;21(9):667–675. doi:10.1007/s11655-014-1982-4
  • Li J, Wang J, Xie Y, Feng Z. Development and validation of the modified patient-reported outcome scale for Chronic Obstructive Pulmonary Disease (mCOPD-PRO). Int J Chron Obstruct Pulmon Dis. 2020;15:661–669. doi:10.2147/COPD.S240842
  • Zhu YB, Li YL, Wang W, Jiang FC. Development of a patient-reported outcome scale for stable chronic obstructive pulmonary disease and its clinical applicability. J Integr Med. 2011;9(08):857–865.
  • Wei R, You LN, Xia J, Lei L, Wu ZY, Pan X. Evaluation of reliability and validity of CFS-COPD-PRO for COPD patients of “cold and fluid” pattern. West J Tradit Chin Med. 2021;34(02):80–84.
  • Zang NZ, Pang LJ, Li P, et al. Establishment and evaluation of IPF-TCM-HRQOL32: a health-related quality of life of TCM scale for patients with idiopathic pulmonary fibrosis. China J Tradit Chin Med Pharm. 2016;31(05):1638–1642.
  • Liang LJ, Liang LR, Dai HP. Research on life quality scale for patients with idiopathic pulmonary fibrosis. Chin J Integr Tradit West Med. 2016;36(06):668–673.
  • Li JS, Wang MH, Yu XQ, Xie Y, Li SY. Development and assessment of efficacy measurement instruments for community-acquired pneumonia. China J Chin Med. 2016;31(11):1654–1661.
  • Diao J. Study on Quality of Life Scale in Patient with Advance Lung Cancer. Nanjing: Nanjing University of Chinese Medicine; 2007.
  • Yang Z, Lu JG, You SF, et al. Development of quality of life assessment system for cancer based on traditional Chinese medicine-lung cancer (QLASTCM-LU). Mod Prev Med. 2011;38(18):3636–3639+3645.
  • Wang TT, He LY, Zhang M, et al. Development of improved version of Quality of Life Assessment Instrument for Lung Cancer Patients Based on Traditional Chinese Medicine (QLASTCM-Lu). Chin J Integr Med. 2019;25(11):831–836. doi:10.1007/s11655-018-2991-5
  • Guan JR. Development of the Scale Combination of Disease and Syndrome of Patient-Reported Outcomes with Bronchiectasis Based on Modern Testing Theory. Henan: Henan University of Chinese Medicine; 2022.
  • Zhao RG. Chinese Food Culture. Beijing: Higher Education Press; 2008.
  • Han G, Ji J. A discussion on Chinese “eating” culture from the greeting “Have you eaten”. Youth Literator. 2009;2009(5):76–77.
  • Hou ZK. On the necessity of developing quality of life instruments in traditional Chinese medicine. J Chin Integr Med. 2011;9(5):468–482. doi:10.3736/jcim20110502
  • Lou CX, Pang ZR, Cui J. Practical significance of health preservation thoughts in Huangdi’s orthodox classic. Li Shizhen Medicine Medical Res. 2009;20(11):2837–2839.
  • Zhou X, Yu CQ, Wang HW, et al. The relationship between Chinese traditional theory of essence-Qi-spirit and health. J Tianjin Univ Trad Chinese Med. 2013;32(1):8–11.
  • Zhang H, Zhang FY, Zhao YN, Li Z. Health concepts under the view of Chinese culture. Chinese J Nurs. 2015;50(10):1236–1239.
  • Paula JJD, Albuquerque MR, Bicalho MAC, Romano-Silva MA. Confirmatory factor analysis of the general activities of daily living scale: further evidences of internal validity. Braz J Psychiatry. 2017;39(4):379–380. doi:10.1590/1516-4446-2017-2256
  • Devellis RB. Scale Development: Theory and Applications 3ed. Chongqing: Chongqing University Press; 2016.
  • Moreira RS, Bassolli L, Coutinho E, et al. Reproducibility and reliability of the quality of life questionnaire in patients with atrial fibrillation. Arq Bras Cardiol. 2016;106(3):171–181. doi:10.5935/abc.20160026
  • Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res. 2012;21(4):651–657. doi:10.1007/s11136-011-9960-1
  • Elsman EBM, Butcher NJ, Mokkink LB, et al. Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments. Syst Rev. 2022;11(1):121. doi:10.1186/s13643-022-01994-5
  • Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res. 2021;30(8):2197–2218. doi:10.1007/s11136-021-02822-4